Effectiveness and process evaluation in obesity and type 2 diabetes prevention programs in children: a systematic

M Seral-Cortes1,2, P De Miguel-Etayo3,4, P Zapata1,5

  • 1Growth, Exercise, NUtrition and Development (GENUD) Research Group, Instituto Agroalimentario de Aragón (IA2), Instituto de Investigación Sanitaria, Aragón (IIS Aragón), Universidad de Zaragoza, 50009, Zaragoza, Spain.

BMC Public Health
|February 13, 2021
PubMed

Insights

Process evaluation (PE) improves the effectiveness of childhood obesity and Type 2 Diabetes Mellitus (T2DM) prevention interventions. Studies with PE showed positive BMI changes, unlike those without it, highlighting PE

Area of Science:

  • Public Health
  • Pediatrics
  • Metabolic Disorders

Background:

  • Childhood obesity and Type 2 Diabetes Mellitus (T2DM) are critical public health issues.
  • Process evaluation (PE) is increasingly vital for complex health interventions.
  • Existing interventions often lack comprehensive PE, impacting their effectiveness.

Purpose of the Study:

  • To assess the effectiveness of interventions for childhood obesity and T2DM prevention on body composition.
  • To evaluate the implementation and reporting of process evaluation (PE) in these studies.
  • To determine if adherence to PE guidelines influences intervention outcomes.

Main Methods:

  • A systematic literature review was conducted by two independent reviewers.
  • 41 studies meeting inclusion criteria were selected for analysis.
  • Meta-analysis of BMI and zBMI, with subgroup analysis based on PE implementation.

Main Results:

  • Overall interventions showed non-significant effects on BMI and zBMI.
  • Studies incorporating PE demonstrated significant positive effects on BMI.
  • PE was reported in 42% of effective studies and 57% of non-effective studies; fidelity and satisfaction were common PE components, but overall PE use was low (7/41).

Conclusions:

  • Childhood obesity and T2DM prevention interventions lack effectiveness based on BMI and zBMI.
  • Process evaluation (PE) is associated with improved BMI outcomes.
  • Inconsistent and incomplete reporting of PE components limits understanding and replication of effective interventions.
Abstract

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.8K
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
13.0K
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
919
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
75
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
699
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
264